Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04840212 · ClinicalTrials.gov registry record · NA
The Effectiveness of Aromatherapy in an Urban, Safety-Net Hospital on Pain
A NA study, sponsored by Parkland Health and Hospital System.
- Completed
- Registry status
- NA
- Development phase
- 184
- Enrollment target
NCT04840212: Completed NA study, sponsored by Parkland Health and Hospital System.
NCT04840212 is a NA study that has completed, run by Parkland Health and Hospital System. The registered enrollment target is 184 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04840212, a NA study, has completed, sponsored by Parkland Health and Hospital System.
- COMPLETED
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
Study Summary
The purpose of this project is to evaluate the effectiveness of aromatherapy on reducing pain in the acute care setting at Parkland Health and Hospital System. The target population for this study will be patients who are recovering from surgical procedures and are in the Surgical Services inpatient units.
Primary Outcome
Pain scale is measured by patients verbal report of pain and ranges from 0 to 10 , with higher scores indicating more pain and thus a worse outcome.
Interventions
- OTHER Lavender-Sandalwood scented aromatherapy sticker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2023-03-15 |
| Phase | NA |
What the finished NCT04840212 record still lists
NCT04840212 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which Lavender-Sandalwood scented aromatherapy sticker is the first listed.
NCT04840212 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04840212 about?
NCT04840212 is a clinical study titled "The Effectiveness of Aromatherapy in an Urban, Safety-Net Hospital on Pain". The purpose of this project is to evaluate the effectiveness of aromatherapy on reducing pain in the acute care setting at Parkland Health and Hospital System. The target population for this study will be patients who are recovering from surgical procedures and are in the Surgical Services inpatient...
What is the current status of trial NCT04840212?
This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2021-03-01. Estimated completion is 2023-03-15.
What interventions are being tested in trial NCT04840212?
The interventions under investigation include: Lavender-Sandalwood scented aromatherapy sticker (OTHER).
Who is sponsoring clinical trial NCT04840212?
This trial is sponsored by Parkland Health and Hospital System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04840212's enrollment target sits among peer trials
184 581st of 2000 higher than 1,417 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI